Daly City, CA, United States of America

Creighton Buie

This inventor holds 2 USPTO granted patents and 1 published patent application and 1 EPO patent. Top assignee: Life Technologies Corporation. Active years: 2020-2025.

USPTO Granted Patents = 2 

% Patents Active = 100.0

 

Average Co-Inventor Count = 3.0

ph-index = 1

Forward Citations = 8(Granted Patents)


Company Filing History:


Years Active: 2020-2025

Loading Chart...
Loading Chart...
2 patents (USPTO):Explore Patents

Title: Creighton Buie: Innovator in Multilane Flow Cell Technology

Introduction: Creighton Buie is a prominent inventor based in Daly City, California. With a focus on advancing technology in the field of life sciences, Buie has made significant contributions through his patented invention of a multilane flow cell. Currently, he is employed with Life Technologies Corporation, where he continues to push the boundaries of innovation.

Latest Patents: Creighton Buie holds a patent for a multilane flow cell, a technology that has the potential to enhance sample analysis and processing in various applications within life science research. This invention showcases his commitment to improving accuracy and efficiency in scientific workflows.

Career Highlights: Buie's career at Life Technologies Corporation has been marked by his dedication to research and development. His work in creating innovative solutions has helped the company maintain its status as a leader in life sciences technology.

Collaborations: Throughout his career, Buie has collaborated with notable colleagues, including Albert L. Carrillo and Mark T. Reed. These partnerships have fostered an environment of creativity and innovation, resulting in new advancements in their respective fields.

Conclusion: Creighton Buie's contributions to technology, particularly through his multilane flow cell patent, underline the vital role inventors play in shaping the future of life sciences. His ongoing work at Life Technologies Corporation and collaborations with esteemed colleagues promise to deliver even more groundbreaking advances in the years to come.

Profile summary based on public USPTO records.
Please report any incorrect information to [email protected]
Loading…